AEON Biopharma (AEON) Competitors $0.49 -0.02 (-4.46%) Closing price 04:00 PM EasternExtended Trading$0.53 +0.04 (+8.64%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock AEON vs. IPA, MIRA, CGTX, QTTB, NNVC, NAII, XFOR, LSTA, PASG, and VYNEShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include ImmunoPrecise Antibodies (IPA), MIRA Pharmaceuticals (MIRA), Cognition Therapeutics (CGTX), Q32 Bio (QTTB), NanoViricides (NNVC), Natural Alternatives International (NAII), X4 Pharmaceuticals (XFOR), Lisata Therapeutics (LSTA), Passage Bio (PASG), and VYNE Therapeutics (VYNE). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. ImmunoPrecise Antibodies MIRA Pharmaceuticals Cognition Therapeutics Q32 Bio NanoViricides Natural Alternatives International X4 Pharmaceuticals Lisata Therapeutics Passage Bio VYNE Therapeutics ImmunoPrecise Antibodies (NASDAQ:IPA) and AEON Biopharma (NASDAQ:AEON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends. Does the MarketBeat Community believe in IPA or AEON? ImmunoPrecise Antibodies received 7 more outperform votes than AEON Biopharma when rated by MarketBeat users. However, 100.00% of users gave AEON Biopharma an outperform vote while only 93.75% of users gave ImmunoPrecise Antibodies an outperform vote. CompanyUnderperformOutperformImmunoPrecise AntibodiesOutperform Votes1593.75% Underperform Votes16.25%AEON BiopharmaOutperform Votes8100.00% Underperform VotesNo Votes Which has stronger earnings & valuation, IPA or AEON? ImmunoPrecise Antibodies has higher revenue and earnings than AEON Biopharma. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than AEON Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise Antibodies$24.00M0.93-$20.13M-$1.16-0.42AEON BiopharmaN/AN/A-$36.63M$298.120.00 Is IPA or AEON more profitable? AEON Biopharma has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -114.50%. AEON Biopharma's return on equity of 0.00% beat ImmunoPrecise Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise Antibodies-114.50% -73.74% -42.68% AEON Biopharma N/A N/A -994.63% Do insiders and institutionals hold more shares of IPA or AEON? 6.7% of ImmunoPrecise Antibodies shares are owned by institutional investors. Comparatively, 22.8% of AEON Biopharma shares are owned by institutional investors. 6.8% of ImmunoPrecise Antibodies shares are owned by insiders. Comparatively, 0.9% of AEON Biopharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, IPA or AEON? ImmunoPrecise Antibodies has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500. Comparatively, AEON Biopharma has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Do analysts rate IPA or AEON? ImmunoPrecise Antibodies currently has a consensus target price of $4.00, suggesting a potential upside of 718.16%. AEON Biopharma has a consensus target price of $360.00, suggesting a potential upside of 73,974.07%. Given AEON Biopharma's higher probable upside, analysts plainly believe AEON Biopharma is more favorable than ImmunoPrecise Antibodies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor IPA or AEON? In the previous week, ImmunoPrecise Antibodies and ImmunoPrecise Antibodies both had 4 articles in the media. ImmunoPrecise Antibodies' average media sentiment score of 0.00 equaled AEON Biopharma'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ImmunoPrecise Antibodies 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AEON Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAEON Biopharma beats ImmunoPrecise Antibodies on 8 of the 14 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.12M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio2.708.9226.8419.71Price / SalesN/A250.96391.39116.98Price / CashN/A65.8538.2534.62Price / Book-0.126.466.794.50Net Income-$36.63M$143.98M$3.23B$248.18M7 Day Performance-2.39%3.04%4.07%1.14%1 Month Performance21.50%7.44%12.52%15.20%1 Year Performance-99.59%-2.46%16.83%6.56% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma1.8244 of 5 stars$0.49-4.5%$360.00+73,974.1%-99.6%$5.12MN/A2.705IPAImmunoPrecise Antibodies2.2639 of 5 stars$0.45+0.3%$4.00+788.7%-57.8%$20.60M$24.00M-0.5880News CoverageMIRAMIRA Pharmaceuticals2.1471 of 5 stars$1.22flat$14.00+1,047.5%+54.1%$20.51MN/A-2.182News CoverageEarnings ReportCGTXCognition Therapeutics2.5594 of 5 stars$0.33+8.6%$6.13+1,773.7%-83.9%$20.26MN/A-0.3420Gap DownQTTBQ32 Bio2.1325 of 5 stars$1.66+7.1%$24.71+1,388.8%-94.1%$20.25M$-6,651,000.00-0.1239Positive NewsGap UpNNVCNanoViricidesN/A$1.28-3.0%N/A-25.9%$20.04MN/A-1.7820NAIINatural Alternatives International0.719 of 5 stars$3.22-0.3%N/A-50.0%$19.96M$121.85M-2.50290News CoveragePositive NewsEarnings ReportAnalyst ForecastGap UpXFORX4 Pharmaceuticals4.5838 of 5 stars$3.34-0.9%$72.33+2,065.7%-90.0%$19.34M$31.36M-37.1180LSTALisata Therapeutics2.8096 of 5 stars$2.23+6.2%$15.00+572.3%-9.7%$19.22M$1M-0.8930Gap UpPASGPassage Bio2.1049 of 5 stars$0.31-6.3%$7.50+2,332.7%-76.0%$19.16MN/A-0.26130VYNEVYNE Therapeutics1.9755 of 5 stars$1.25-3.8%$6.25+400.0%-57.9%$19.01M$501,000.00-1.4530High Trading Volume Related Companies and Tools Related Companies IPA Alternatives MIRA Alternatives CGTX Alternatives QTTB Alternatives NNVC Alternatives NAII Alternatives XFOR Alternatives LSTA Alternatives PASG Alternatives VYNE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AEON Stock Free AEON Stock Alerts